Behavioral outcomes of EGF and bFGF primed-mesenchymal stem cells used in the treatment of an R6/2 rodent model of Huntington’s disease

Research output: Other contribution

Original languageEnglish
StatePublished - Dec 2014

Fingerprint

Dive into the research topics of 'Behavioral outcomes of EGF and bFGF primed-mesenchymal stem cells used in the treatment of an R6/2 rodent model of Huntington’s disease'. Together they form a unique fingerprint.

Cite this